LAYERBIO INC

LEXINGTON, MA · Founded 2013 · Medtech · Acquired

Bioerodible sustained-release coating technology for intraocular lenses that gradually delivers therapeutic agents post-cataract surgery

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · layerbio.com

Sector: Medtech
Headquarters: LEXINGTON, MA
Founded: 2013
Latest Form D: $50K, Jun 2021
Total capital: $2.8M

Federal grants: $2.6M; 9 awards · 2014–2019; Rank in peer group#82 of 445
Private capital raised: $255K; 2 Form D · last Jun 2021; 64 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 8 pending · first 2021; Rank in peer group#109 of 445

Capital timeline

Latest events

Jun 2021Private capital raisedForm D · SEC · 2nd filing$50K
Apr 2019Federal grantHealth and Human S · Phase II · Sustained Release Travoprost Implant for Treatment of Glaucoma$642K
Jan 2019Federal grantHealth and Human S · Phase II · Sustained Release Travoprost Implant for Treatment of Glaucoma$98K
Apr 2018Federal grantHealth and Human S · Phase II · Sustained Release Travoprost Implant for Treatment of Glaucoma$485K
Jul 2017Federal grantHealth and Human S · Phase I · Platform Delivery Technology for Nucleic Acid Therapeutics to Promote Wound Healing$325K
Jul 2017Federal grantHealth and Human S · Phase I · Platform Delivery Technology for Nucleic Acid Therapeutics to Promote Wound Healing$325K
Sep 2015Federal grantHealth and Human S · Phase I · Drug-Eluting Intraocular Lens$24K
Jul 2014Private capital raisedForm D · SEC · 1st filing$205K

Show 3 earlier federal awards

Jan 2015Federal grantHealth and Human S · Phase I · Drug-Eluting Intraocular Lens$263K
Jan 2015Federal grantNSF · Phase I · SBIR Phase I: Multi-month, Nanoparticle Drug Delivery System For the Treatment of Glaucoma$150K
Dec 2014Federal grantHealth and Human S · Phase I · Drug-Eluting Intraocular Lens$238K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

Federal grants#82 · top 18%
Granted patents#109 · top 24%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Kenneth J. MandellResearcherExecutive Officer, DirectorLinked by $413K in grants as PI
Augustine W. LawlorDirectorNamed in SEC Form D filings
Charles T. CooneyDirectorNamed in SEC Form D filings
John W. LittlechildDirectorNamed in SEC Form D filings
Paula T. HammondDirectorNamed in SEC Form D filings
Tracy M. ValorieDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 9

Feb 9, 2023PendingOcular Device Delivery Methods And SystemsUSPTOApplication 17742847
Nov 30, 2021GrantedOcular Device Delivery Methods And SystemsUSPTOUS 11,185,441
Feb 2, 2017PendingSustained-release Drug Formulations For GlaucomaUSPTOApplication 15221257

Show all 9 patent records

Ocular Device Delivery Methods And SystemsFeb 9, 2023 · Application 17742847Pending
Ocular Device Delivery Methods And SystemsNov 30, 2021 · US 11,185,441Granted
Sustained-release Drug Formulations For GlaucomaFeb 2, 2017 · Application 15221257Pending
Intraocular Lens Drug Delivery SystemApplication 63012994Pending
Intraocular Lens Drug Delivery SystemApplication 62867233Pending
Sustained-release Drug Formulations For GlaucomaApplication PCTUS2016044271Pending
Sustained-Release Drug Formulations For GlaucomaApplication 62197921Pending
Ocular Device Delivery Methods And SystemsApplication 17495369Pending
Ocular Device Delivery Methods And SystemsApplication PCTUS2020039990Pending

Instapath Inc.Similar federal contract value in Medtech · null in contracts
ESCULON LLCSimilar federal contract value in Medtech · null in contracts
Birkeland Current LLCSimilar federal contract value in Medtech · null in contracts
Hura Imaging, Inc.Similar federal contract value in Medtech · null in contracts
Integral Biosystems, LLCSimilar federal contract value in Medtech · null in contracts
COHERE-MED, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.